INS and diabetes mellitus: Another limitation of the study is that the residue defects of STZ-induced diabetic model after the insulin treatment may potentially result from either diabetes or the previously unattended direct effects of STZ on non-beta cells; hence, further studies using a different model of diabetes are warranted.